Stabilized FTO reduced m6A methylation on pyrroline-5-carboxylate reductase 1 (PYCR1) and extended PYCR1 mRNA half-life to promote BLCA cell proliferation and migration in vitro as well as tumor growth in vivo. The gene discussed is FTO; the disease is bladder transitional cell carcinoma.